{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:49Z","timestamp":1786991149307,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.jaad.2005.09.015","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T12:22:44Z","timestamp":1196079764000},"page":"S69-S71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"S","title":["Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis"],"prefix":"10.1016","volume":"57","author":[{"given":"Annabel","family":"Maruani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wierzbicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Machet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Abdallah-Lotf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"de Muret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Machet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.09.015_bib1","first-page":"173","article-title":"Pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression","volume":"133","author":"Nalesnik","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2005.09.015_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.bmt.1703806","article-title":"Post-transplant lymphoproliferative disorder: a review","volume":"31","author":"Loren","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaad.2005.09.015_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199305063281806","article-title":"Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis","volume":"328","author":"Kamel","year":"1993","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaad.2005.09.015_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0025-6196(11)63231-X","article-title":"Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate","volume":"76","author":"Tournadre","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2005.09.015_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0046-8177(94)90295-X","article-title":"Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression","volume":"25","author":"Kamel","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaad.2005.09.015_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1600-0609.2002.02748.x","article-title":"Epstein-Barr virus-associated lymphoproliferative disease occurring in a patient with sarcoidosis treated by methotrexate and methylprednisolone","volume":"69","author":"Theate","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaad.2005.09.015_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archderm.1997.03890430083011","article-title":"Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis","volume":"133","author":"Paul","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.09.015_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00000372-200210000-00008","volume":"24","author":"Blokx","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2005.09.015_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0168-8278(00)80406-7","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases","volume":"32","author":"Zompi","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2005.09.015_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.beha.2004.05.007","article-title":"Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease","volume":"17","author":"Heslop","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jaad.2005.09.015_bib11","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1200\/JCO.1996.14.6.1943","article-title":"Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatoic diseases","volume":"14","author":"Salloum","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2005.09.015_bib12","first-page":"1174","article-title":"Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection","volume":"22","author":"Liote","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2005.09.015_bib13","first-page":"1676","article-title":"A population based, case control study of non-Hodgkin's lymphoma in patients with rheumatoid arthritis","volume":"26","author":"Kamel","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2005.09.015_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/jnci\/djh313","article-title":"Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas","volume":"96","author":"Feng","year":"2004","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205030069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205030069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:07:22Z","timestamp":1759270042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205030069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0190962205030069"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.09.015","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}